Fitoplancton Marino
Spanish marine biotech founded in 2002 that cultivates marine microalgae via proprietary closed bioreactors, producing patented TetraSOD® nutraceutical ingredients and consumer brands serving nutraceutical, cosmetic, aquaculture, aquariology, and human nutrition markets worldwide.
- Company typePrivate
- Founded2002
- HeadquartersEl Puerto De Santa María, Spain
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Fitoplancton Marino does
Fitoplancton Marino S.L. is a Spanish marine biotechnology company founded in 2002 in El Puerto de Santa María, Cádiz, that cultivates marine microalgae using proprietary closed outdoor bioreactor systems developed in-house by its engineering and R&D departments. The company operates across five product divisions — Functional Ingredients (TetraSOD®), Human Nutrition (Plancton Marino Veta la Palma®), Dermocosmetics (Dermalgae® and Rejuvasea®), Aquaculture (easy algae®), and Aquariology (easyreefs®) — and is the first and only company in the world to hold both European Novel Food authorization and US GRAS status for marine microalgae for human consumption. Its 10 patents and 17 peer-reviewed studies underpin TetraSOD®, a patented bioactive complex with high Superoxide Dismutase content used in oxidative-stress nutraceuticals, and a proprietary RT-qPCR molecular biology platform enables metabolic monitoring and quality control.
The company's revenue model combines B2B sales of functional ingredients to nutraceutical, food, cosmetic, and aquaculture manufacturers with direct-to-consumer sales of finished products (Plancton Marino for gastronomy, Rejuvasea® cosmetics via majority-owned GMPC LLC in US/Canada). Geographic reach is enabled through exclusive distribution partnerships — Lonza distributes TetraSOD® under the Oceanix™ brand in the US and Canada for healthy aging and sports nutrition, and SUANNUTRA USA holds North American distribution rights. The company employs 11-50 staff, including a 12-person R&D team with 3 PhDs, and has historically allocated approximately 45% of business volume to research, totaling €5M over seven years pre-2014. Fitoplancton Marino has been part of Grupo Hisparroz, linked to multinational EBRO Foods, since 2011, and operates its production facilities near Doñana Natural Park with annual microalgae output of approximately 1,500 kg.
Fitoplancton Marino firmographics
Firmographics- Name
- Fitoplancton Marino
- Legal name
- Fitoplancton Marino S.L.
- Website
- https://fitoplanctonmarino.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Spanish marine biotech founded in 2002 that cultivates marine microalgae via proprietary closed bioreactors, producing patented TetraSOD® nutraceutical ingredients and consumer brands serving nutraceutical, cosmetic, aquaculture, aquariology, and human nutrition markets worldwide.
- Ownership category
- akta.pro rank
Fitoplancton Marino industry classification
Industry- Product category
- Marine Biotechnology / Microalgae-based Ingredients
- NAICS
- Aquaculture (1125)
- SIC
- Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Seaweed & Algae Aquaculture (incl. microalgae) (AFAEAAAE)
- akta.pro secondary industries
- Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF), Hatchery & Larval Feed (Microdiets, Live Feed Enrichment) (AFADADAE), Live Feed & Hatchery Inputs Production (Artemia, Rotifers, Copepods, Microalgae Cultures) (AFAEAKAJ), Aquaculture Feed & Nutrition (farm-level feed programs) (AFAEAAAL)
Keywords
Where Fitoplancton Marino is headquartered
LocationHeadquarters
- HQ city
- El Puerto De Santa María
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Fitoplancton Marino business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Functional Ingredients (TetraSOD®): Sale of TetraSOD®, a patented bioactive marine complex ingredient, to food, supplement, and nutraceutical manufacturers. The ingredient is backed by 17 peer-reviewed studies and 10 patents, with clinical evidence supporting benefits in metabolic health, physical performance, and cellular health. Distributed globally through Fitoplancton Marino and via partners like Lonza (Oceanix™ brand in US/Canada) and SUANNUTRA USA.
- Human Nutrition Products (Plancton Marino): B2C and B2B sales of Plancton Marino Veta la Palma®, a freeze-dried marine microalgae product marketed as an authentic sea flavor enhancer for gastronomy. Sold to restaurants, gastrobars, and directly to consumers through planctonmarino.com. The only Novel Food authorized marine microalgae product for human consumption in Europe.
- Cosmetic Ingredients and Rejuvasea®: Sale of purified extracts and fractions for use in cosmetic products by major international brands, plus direct sales of Rejuvasea® branded cosmetic products in US and Canada through majority-owned subsidiary GMPC LLC.
- Aquaculture Products (easy algae®): Sale of microalgae products (freeze-dried, pastes, concentrates), microalgae strains, starter cultures, and culture media to aquaculture operations for fish, crustacean, and mollusk larval feeding and enrichment.
- Aquariology Products (easyreefs®): Sale of microalgae and zooplankton products for marine aquariums under the easyreefs® brand. Products include gels, freeze-dried formats, Easydose, and Masstick, distributed throughout Europe and internationally.
Go-to-market motion3 records
Distribution channels6 records
Marketing channels5 records
Fitoplancton Marino product offering
Product offeringCore offering
Fitoplancton Marino cultivates marine microalgae using proprietary closed outdoor bioreactor technology and produces a portfolio of microalgae-based ingredients and finished products. Its core offerings include the patented TetraSOD® bioactive complex (high-SOD ingredient for nutraceuticals), Plancton Marino Veta la Palma® lyophilized marine plankton for gastronomy, Dermalgae® and Rejuvasea® dermocosmetic extracts, easy algae® aquaculture feeds, and easyreefs® aquariology products.
Product overview
Fitoplancton Marino is a marine biotech company offering a portfolio of marine microalgae-based products across five business divisions: Functional Ingredients (TetraSOD®), Human Nutrition (Plancton Marino Veta la Palma®), Dermocosmetics (Dermalgae® and Rejuvasea®), Aquaculture (easy algae®), and Aquariology (easyreefs®). The core technology revolves around sustainable cultivation of marine microalgae in closed outdoor bioreactors, with proprietary processes for extracting bioactive compounds. Products range from bulk ingredients (TetraSOD®) and food products (Plancton Marino) to finished consumer products (cosmetics, aquaculture feeds) and are distributed globally through partnerships including Lonza (Oceanix™ brand in North America) and SUANNUTRA USA.
Differentiator
Problem solved
Functional benefit
Brands
- Dermalgae®: Therapeutic bioactive natural therapy with Marine Plankton extract for sensitive and intolerant skin conditions.
- Rejuvasea®
- Rejuvasea®
Products and services
- TetraSOD® Patented bioactive marine complex derived from microalgae with high Superoxide Dismutase (SOD) activity. The most concentrated natural SOD source on the market, designed for oxidative stress prevention in functional foods, nutraceuticals, and sports nutrition. Effective at a 25 mg daily dose. Backed by 17 peer-reviewed studies and 10 patents. Distributed globally by Lonza under the Oceanix™ brand in the US/Canada and by SUANNUTRA USA in North America.
- Plancton Marino Veta la Palma® Lyophilized (freeze-dried) marine plankton for human consumption, marketed as an authentic sea flavor enhancer for gourmet cuisine. Rich in omega-3 fatty acids, vitamins, and minerals. Allergen-free, vegan, and 100% natural. Sold to high-end restaurants, gastrobars, and consumers through planctonmarino.com. The only Novel Food-authorized marine microalgae product for human consumption in Europe.
- Dermalgae® Bioactive natural therapy skincare product containing marine plankton extract, developed for therapeutic dermocosmetics targeting sensitive and problematic skin. Achieves over seven different cellular regulations from a single compound. Purified extracts and fractions supplied to important international cosmetic brands worldwide.
- Rejuvasea® Anti-aging cosmetic brand commercialized in the United States and Canada, with all products containing active compounds extracted from Fitoplancton Marino's marine microalgae. Manufactured and sold through majority-owned subsidiary GMPC LLC via rejuvasea.com.
- easy algae® Aquaculture product line including freeze-dried microalgae, pastes, concentrates, microalgae strains, starter cultures, and culture media for fish, crustacean, and mollusk larval feeding and green water technique. Delivers high densities and excellent survival rates in rotifer cultures. Includes Nannochloropsis gaditana (72% of production) and other aquaculture-relevant strains.
- easyreefs® Aquariology product line offering natural marine algae and zooplankton formulations in gellan gum, rehydratable freeze-dried, Easydose, and Masstick formats for marine aquariums, coral, omnivorous fish, and invertebrate nutrition. Distributed throughout Europe (Netherlands, Germany, UK, Italy, Switzerland, Denmark, Norway) and internationally.
Quantifiable outcome
- Effective at just 25mg daily dose
- +3 more outcomes
Companies that use Fitoplancton Marino
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Fitoplancton Marino technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Fitoplancton Marino partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- SUANNUTRA USAcoreSUANNUTRA USA signed a distribution agreement with Fitoplancton Marino to commercialize TetraSOD®, a patented bioactive marine complex derived from microalgae, in the North American market. TetraSOD® is backed by 17 peer-reviewed studies and 10 patents.
- LonzacoreLonza launched Oceanix™ brand in the US and Canada in March 2019, featuring TetraSOD® microalgae ingredient for healthy aging and sports nutrition. Lonza is an integrated solutions provider serving healthcare and nutrition markets.
- Grupo HisparrozcoreFitoplancton Marino joined Grupo Hisparroz in 2011, which is linked to the multinational EBRO Foods. The integration generated synergies in human nutrition and aquaculture sectors.
- MIRACLES Project ConsortiumminorEU Framework Programme 7 KBBE project (number 613588) with 26 partners from 6 EU countries plus Norway and Chile. Focused on developing integrated biorefinery technologies for microalgae products.
- AlgaeCom Project ConsortiumminorEU Framework Programme 7 Industry-Academia Partnerships project (number 286354). Partners include Agricultural University of Athens (Greece), CNRS (France), and Apivita SA (Greece). Aims to exploit microalgae biodiversity for cosmeceutical bioactive ingredients.
- Wageningen UniversityminorResearch partner in MIRACLES project, contributing BioProcess Engineering and Biomass Refinery and Process Dynamics expertise.
- CSIC (Agencia Estatal Consejo Superior de Investigaciones Científicas)minorResearch partner in MIRACLES project representing Spanish scientific research institutions.
- Pesquerías Isla Mayor SA (PIMSA)minorPart of Grupo Hisparroz, provides Marine Fish Breeding Centre located at Finca Veta La Palma as support for aquaculture operations and microalgae applications.
- Algae4A-B Project ConsortiumminorEU Horizon 2020 RISE project (number 691102) focused on exploiting microalgae diversity for aquaculture and cosmetics applications. Partners include CNRS-Cermav (France), IFAPA (Spain), CCMAR (Portugal), and Life Sequencing (Spain).
- GMPC LLCcoreFitoplancton Marino became majority shareholder in GMPC LLC, which manufactures and commercializes Rejuvasea® cosmetic brand in the US and Canada. All products contain active compounds extracted from Fitoplancton Marino's microalgae.
- DEGRANOS Project Partners (Dosbio, Productos Majuelo, Bialimentación de Andalucía, Grupo Siro, La Aurora)minorCDTI Innterconecta project for technological development in valorizing byproducts from cereal and pulse industrialization. Fitoplancton Marino participates as one of six consortium partners.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Fitoplancton Marino competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights7 records
Customer concentration
Fitoplancton Marino social profiles
Digital presenceFitoplancton Marino compliance and trust
Trust signalCompliance5 records
Fitoplancton Marino financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fitoplancton Marino leadership team
Management profileNumber of profiles
Profiles3 records
Fitoplancton Marino subsidiaries and ownership
Company hierarchySubsidiaries1 record
Fitoplancton Marino funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fitoplancton Marino M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fitoplancton Marino
What does Fitoplancton Marino do?
Fitoplancton Marino cultivates marine microalgae using proprietary closed outdoor bioreactor technology and produces a portfolio of microalgae-based ingredients and finished products. Its core offerings include the patented TetraSOD® bioactive complex (high-SOD ingredient for nutraceuticals), Plancton Marino Veta la Palma® lyophilized marine plankton for gastronomy, Dermalgae® and Rejuvasea® dermocosmetic extracts, easy algae® aquaculture feeds, and easyreefs® aquariology products.
Is Fitoplancton Marino a public or private company?
Fitoplancton Marino is a private company. It is classified as corporate owned and is currently operating.
When was Fitoplancton Marino founded?
Fitoplancton Marino was founded in 2002. It employs 11 to 50 people.
Where is Fitoplancton Marino based?
Fitoplancton Marino is headquartered in El Puerto De Santa María, Spain, in the Europe region.
How does Fitoplancton Marino make money?
Five revenue lines are on record. Functional Ingredients (TetraSOD®) is the primary driver. The others are human Nutrition Products (Plancton Marino), cosmetic Ingredients and Rejuvasea®, aquaculture Products (easy algae®) and aquariology Products (easyreefs®).
Does Fitoplancton Marino have an API?
No public API is recorded for Fitoplancton Marino.
What industry is Fitoplancton Marino in?
Fitoplancton Marino's product category is Marine Biotechnology / Microalgae-based Ingredients. Its primary akta.pro industry code is AFAEAAAE, Seaweed & Algae Aquaculture (incl. microalgae), with a secondary code of AFAJAHAF, Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae). Its NAICS code is 1125 and its SIC code is 2000.